Literature DB >> 34060478

How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.

Jonathan Z Li1, Joel N Blankson2.   

Abstract

A small percentage of people living with HIV-1 can control viral replication without antiretroviral therapy (ART). These patients are called elite controllers (ECs) if they are able to maintain viral suppression without initiating ART and posttreatment controllers (PTCs) if they control HIV replication after ART has been discontinued. Both types of controllers may serve as a model of a functional cure for HIV-1 but the mechanisms responsible for viral control have not been fully elucidated. In this review, we highlight key lessons that have been learned so far in the study of ECs and PTCs and their implications for HIV cure research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34060478      PMCID: PMC8159676          DOI: 10.1172/JCI149414

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  112 in total

1.  Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Authors:  Daniel Mendoza; Sarah A Johnson; Bennett A Peterson; Ven Natarajan; Maria Salgado; Robin L Dewar; Peter D Burbelo; Nicole A Doria-Rose; Erin H Graf; Jamieson H Greenwald; Jessica N Hodge; William L Thompson; Nancy A Cogliano; Cheryl L Chairez; Catherine A Rehm; Sara Jones; Claire W Hallahan; Joseph A Kovacs; Irini Sereti; Omar Sued; Sheila A Peel; Robert J O'Connell; Una O'Doherty; Tae-Wook Chun; Mark Connors; Stephen A Migueles
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

2.  Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

Authors:  Hendrik Streeck; Heiko Jessen; Galit Alter; Nickolas Teigen; Mike T Waring; Arne Jessen; Ingrid Stahmer; Jan van Lunzen; Mathias Lichterfeld; Xiaojiang Gao; Todd M Allen; Mary Carrington; Bruce D Walker; Juergen K Rockstroh; Marcus Altfeld
Journal:  J Infect Dis       Date:  2006-08-15       Impact factor: 5.226

Review 3.  The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control.

Authors:  John Zaunders; Wayne B Dyer; Melissa Churchill
Journal:  Curr Opin HIV AIDS       Date:  2011-05       Impact factor: 4.283

4.  Absence of detectable HIV-1 viremia after treatment cessation in an infant.

Authors:  Deborah Persaud; Hannah Gay; Carrie Ziemniak; Ya Hui Chen; Michael Piatak; Tae-Wook Chun; Matthew Strain; Douglas Richman; Katherine Luzuriaga
Journal:  N Engl J Med       Date:  2013-10-23       Impact factor: 91.245

5.  Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Authors:  S R Ostrowski; T L Katzenstein; B K Pedersen; J Gerstoft; H Ullum
Journal:  Scand J Immunol       Date:  2008-12       Impact factor: 3.487

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

7.  Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion.

Authors:  Ivona Pandrea; Thaidra Gaufin; Rajeev Gautam; Jan Kristoff; Daniel Mandell; David Montefiori; Brandon F Keele; Ruy M Ribeiro; Ronald S Veazey; Cristian Apetrei
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

8.  What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.

Authors:  M Bendenoun; A Samri; V Avettand-Fènoël; S Cardinaud; B Descours; G Carcelain; M-C Mazeron; J-F Bergmann; A Urrutia; A Moris; C Rouzioux; F Simon; P Andre; M Pocard; X Dray; T Mourez; V Vieillard; B Autran; F Barin; P Sellier
Journal:  EBioMedicine       Date:  2017-12-07       Impact factor: 8.143

9.  Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.

Authors:  Concepcion Casado; Cristina Galvez; Maria Pernas; Laura Tarancon-Diez; Carmen Rodriguez; Víctor Sanchez-Merino; Mar Vera; Isabel Olivares; Rebeca De Pablo-Bernal; Alberto Merino-Mansilla; Jorge Del Romero; Ramon Lorenzo-Redondo; Ezequiel Ruiz-Mateos; María Salgado; Javier Martinez-Picado; Cecilio Lopez-Galindez
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

10.  Distinct viral reservoirs in individuals with spontaneous control of HIV-1.

Authors:  Chenyang Jiang; Xiaodong Lian; Ce Gao; Xiaoming Sun; Kevin B Einkauf; Joshua M Chevalier; Samantha M Y Chen; Stephane Hua; Ben Rhee; Kaylee Chang; Jane E Blackmer; Matthew Osborn; Michael J Peluso; Rebecca Hoh; Ma Somsouk; Jeffrey Milush; Lynn N Bertagnolli; Sarah E Sweet; Joseph A Varriale; Peter D Burbelo; Tae-Wook Chun; Gregory M Laird; Erik Serrao; Alan N Engelman; Mary Carrington; Robert F Siliciano; Janet M Siliciano; Steven G Deeks; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  Nature       Date:  2020-08-26       Impact factor: 69.504

View more
  6 in total

Review 1.  Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.

Authors:  Rahaman Ademolu Ahmed; Khalid Olajide Adekoya; Chika Kingsley Onwuamah; Bolanle Olufunmilayo Oboh; Smita Swaminathan Iyer; Ayomide Samuel Oluwatosin; Rosemary Ajuma Audu; Oliver Chukwujekwu Ezechi
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

Review 2.  NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses.

Authors:  Leonore Mensching; Angelique Hoelzemer
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

Review 3.  Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches.

Authors:  Jose A Moran; Shireen R Turner; Matthew D Marsden
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 4.  CD8 + T-cell responses in HIV controllers: potential implications for novel HIV remission strategies.

Authors:  Rachel L Rutishauser; Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2022-07-01       Impact factor: 4.061

5.  Combination strategies to durably suppress HIV-1: Soluble T cell receptors.

Authors:  Zoë Wallace; Praveen K Singh; Lucy Dorrell
Journal:  J Virus Erad       Date:  2022-08-24

6.  Selective miRNA inhibition in CD8+ cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses.

Authors:  Nadia Madrid-Elena; Sergio Serrano-Villar; Carolina Gutiérrez; Beatriz Sastre; Matías Morín; Laura Luna; Laura Martín; Javier Santoyo-López; María Rosa López-Huertas; Elena Moreno; María Laura García-Bermejo; Miguel Ángel Moreno-Pelayo; Santiago Moreno
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.